Within the EU project NEOBRAIN (Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants), scientists will collaborate in order to identify strategies to diagnose and to protect the newborn brain against such insults.
In NEOBRAIN, small and medium enterprises collaborate with academic research groups. The project links scientists from a total of 13 partner institutions. The involvement of the companies provides a unique opportunity for using the research results in product development without delay. Publication of project findings in high-profile journals will disseminate new research results and resulting applications on an international level. Scientific coordinator for the entire EU project NEOBRAIN is Prof. Dr. Olaf Dammann from Hannover Medical School, Germany. Patent research and press information will be coordinated in Innsbruck.Name of participating organisation (Short name,City, Country)
In addition to the worry for parents and relatives of prematurely born children, the increasing number of premature babies also has economic effects: across the EU, between six and seven billion euros per year are spent on treating premature babies. It is not possible to apply the results of medical research obtained in adults reliably to premature babies. Therefore the medical profession faces the problem that not only is there no marker for early diagnosis of brain damage, there is also no prophylaxis or therapy that protects the brain.
New approaches in research
It is precisely at this point that the NEOBRAIN comes in. The EU research project, which runs for three years, aims to:
1. find biomarkers for early brain damage. In various animal tests the mechanisms leading to brain damage will be investigated. Moreover, a clinical study of children born before the 28th week of pregnancy is planned in order to develop marker profiles.
2. develop strategies for protecting the brain. Here too animal tests will be carried out. Only the most promising results will find their way into clinical research.
3. create a clinical platform as research network for future European and international studies.
4. develop medication within the three year project period and beyond.
The results of neonatal basic research will thus feed directly into clinical research. New findings and therapeutic approaches gained in this way will be introduced rapidly into clinical practice in neonatal intensive care.NEOBRAIN budget
Mag. Uwe Steger | alfa
Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University
Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
23.08.2017 | Life Sciences
23.08.2017 | Life Sciences
23.08.2017 | Physics and Astronomy